SAVA - Cassava Sciences, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Austin,
United States
Type: Equity
SAVA price evolution
SAVA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $207.29 | $124.17 | $121.14 | |
| Short term investments | ||||
| Net receivables | $1.27 | $1.43 | $1 | $0.96 |
| Inventory | ||||
| Total current assets | $202.55 | $222.12 | $134 | $129.63 |
| Long term investments | ||||
| Property, plant & equipment | $21.14 | $21.36 | $21.6 | $21.85 |
| Goodwill & intangible assets | $0.08 | $0.12 | $0.18 | |
| Total noncurrent assets | $21.45 | $21.72 | $22.03 | |
| Total investments | ||||
| Total assets | $223.75 | $243.57 | $155.72 | $151.66 |
| Current liabilities | ||||
| Accounts payable | $52.24 | $52.55 | $9.6 | $10.57 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $57.03 | $54.59 | $77.12 | $14.2 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $57.11 | $54.59 | $77.12 | $14.2 |
| Shareholders' equity | ||||
| Retained earnings | -$377.51 | -$349.57 | -$355.73 | -$380.77 |
| Other shareholder equity | ||||
| Total shareholder equity | $188.97 | $78.6 | $137.47 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $121.14 | $201.01 | $233.44 | $93.51 |
| Short term investments | ||||
| Net receivables | $0.96 | |||
| Inventory | ||||
| Total current assets | $129.63 | $211.23 | $244.48 | $93.99 |
| Long term investments | ||||
| Property, plant & equipment | $21.85 | $22.99 | $20.83 | $0.31 |
| Goodwill & intangible assets | $0.18 | $0.62 | $1.07 | |
| Total noncurrent assets | $22.03 | $23.61 | $22.3 | $0.31 |
| Total investments | ||||
| Total assets | $151.66 | $234.83 | $266.78 | $94.3 |
| Current liabilities | ||||
| Accounts payable | $10.57 | $4.02 | $7.13 | $0.91 |
| Deferred revenue | ||||
| Short long term debt | $0.1 | $0.1 | $0.06 | |
| Total current liabilities | $14.2 | $7.06 | $12.53 | $1.86 |
| Long term debt | $0.04 | $0.14 | $0.23 | |
| Total noncurrent liabilities | $0.23 | $0.33 | $0.23 | |
| Total debt | $0.14 | $0.24 | $0.29 | |
| Total liabilities | $14.2 | $7.29 | $12.87 | $2.1 |
| Shareholders' equity | ||||
| Retained earnings | -$380.77 | -$283.55 | -$207.31 | -$174.92 |
| Other shareholder equity | ||||
| Total shareholder equity | $137.47 | $227.54 | $253.91 | $92.2 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $15.2 | $16.23 | $18.73 | |
| Selling, general & administrative | $46.2 | $3.7 | $4.06 | |
| Total operating expenses | $61.4 | $19.93 | $22.79 | |
| Operating income | -$61.4 | -$19.93 | -$22.79 | |
| Income from continuing operations | ||||
| EBIT | $6.16 | $25.04 | -$20.92 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | $6.16 | $25.04 | -$20.92 | |
| Income (for common shares) | $6.16 | $25.04 | -$20.92 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $89.42 | $68.03 | $24.81 | $3.05 |
| Selling, general & administrative | $16.53 | $11.99 | $8.05 | $3.74 |
| Total operating expenses | $105.96 | $80.02 | $32.87 | $6.45 |
| Operating income | -$105.96 | -$80.02 | -$32.87 | -$6.45 |
| Income from continuing operations | ||||
| EBIT | -$97.22 | -$76.25 | -$32.38 | -$6.33 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$97.22 | -$76.25 | -$32.38 | -$6.33 |
| Income (for common shares) | -$97.22 | -$76.25 | -$32.38 | -$6.33 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $6.16 | $25.04 | -$20.92 | |
| Operating activities | ||||
| Depreciation | $0.3 | $0.31 | $0.36 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.6 | $2.33 | $2.13 | |
| Total cash flows from operations | -$18.24 | -$19.13 | -$22.32 | |
| Investing activities | ||||
| Capital expenditures | -$0.03 | -$0.04 | ||
| Investments | ||||
| Total cash flows from investing | -$0.05 | -$0.03 | -$0.04 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $101.39 | $22.16 | $1.14 | |
| Net borrowings | ||||
| Total cash flows from financing | $123.55 | $101.39 | $22.16 | $1.14 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $67.84 | $83.12 | $3.03 | -$21.21 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$97.22 | -$76.25 | -$32.38 | -$6.33 |
| Operating activities | ||||
| Depreciation | $1.53 | $1.3 | $0.53 | $0.02 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.59 | $2.07 | $1.76 | $0.99 |
| Total cash flows from operations | -$82.03 | -$77.51 | -$30.2 | -$5.38 |
| Investing activities | ||||
| Capital expenditures | -$0.41 | -$2.71 | -$22.21 | $0.36 |
| Investments | ||||
| Total cash flows from investing | -$0.41 | -$2.71 | -$22.21 | $0.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.56 | $47.8 | $192.34 | $75.45 |
| Net borrowings | ||||
| Total cash flows from financing | $2.56 | $47.8 | $192.34 | $75.45 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$79.88 | -$32.42 | $139.93 | $70.42 |
News
Fundamentals
| Market cap | $105.55M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 47.98M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.10 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.55 |
| Quick ratio | N/A |